RxDoctor Payments DataLook up a doctor →

Abhijit Raval, MD

Pulmonary Disease · Anderson, SCNPI 1508052275

Payments from drug & device makers

$3,027,265in general payments, 2019–2025

Across 2,347 payments — averaging $1289.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insmed, Inc.$695K
  • United Therapeutics Corporation$500K
  • Actelion Pharmaceuticals US, Inc.$322K
  • GSK$264K
  • Sanofi$203K
  • Intuitive Surgical$162K
  • plus $881K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Insmed, Inc.389$694,751
United Therapeutics Corporation381$499,867
Actelion Pharmaceuticals US, Inc.329$321,998
GSK183$264,336
Sanofi116$203,040
Intuitive Surgical129$162,267
AstraZeneca(2 entities)175$158,474
Boehringer Ingelheim150$146,031
Bayer100$95,936
Merck51$84,604
Mylan Specialty L.p.107$78,521
E.r. Squibb & Sons, L.L.C.8$74,519
Mallinckrodt Hospital Products Inc.34$57,673
Janssen Research & Development, LLC32$46,561
Gyrus ACMI, Inc.4$25,162
Regeneron Healthcare Solutions, Inc.15$23,622
Johnson & Johnson(3 entities)31$21,842
Actelion Pharmaceuticals, Ltd6$16,830
Sanofi US Services Inc.1$13,229
Mannkind Corporation3$11,500
Viatris Specialty LLC12$10,802
Astrazeneca UK Limited1$5,857
Portola Pharmaceuticals, LLC3$2,997
Pinnacle Biologics, Inc9$1,959
Gilead4$1,782
Veran Medical Technologies, Inc.7$1,730
Olympus America Inc.6$257
Electromed, Inc.23$238
Philips North America LLC5$108
Galvanize Therapeutics, Inc1$98
Sanofi-aventis U.S. LLC1$57
Inari Medical, Inc.1$50
ANI Pharmaceuticals, Inc.2$43
Novartis2$41
Amgen2$40
Ambu Inc.1$35
Teva Pharmaceuticals USA, Inc.2$33
Incyte Corporation2$29
Cook Medical LLC1$25
Grifols USA, LLC1$24
Biofire Diagnostics, LLC1$24
Shockwave Medical, Inc1$23
CSL Behring1$23
Pharming Healthcare, Inc.1$23
Inspire Medical Systems, Inc.1$21
Myriad Genetic Laboratories, Inc.1$18
Olympus Corporation Of The Americas1$18
Healthmyne, Inc.1$17
Advanced Respiratory, Inc1$16
Coherus Oncology, Inc.1$16
AbbVie1$15
Resmed Corp1$14
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$14
Takeda Pharmaceuticals U.S.A., Inc.1$14
Bioxcel Therapeutics, Inc.1$14
Seagen Inc.1$13
Mallinckrodt Enterprises LLC1$13

How this compares

$3,027,265 in reported general payments places this provider in the 95th percentile of 192 pulmonary disease providers in South Carolina.

See all pulmonary disease providers in South Carolina →

Medicare billing

Part B allowed, 2024
$300,903
Medicare patients
809
Services billed
3,588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Anderson

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →